Antibodies |
|
Biotin CD3 Monoclonal Antibody (UCHT1) |
eBioscience |
Cat#13-0038-82, RRID:AB_466323
|
Biotin Mouse Anti-Human CD8 (RPA-T8) |
BD |
Cat#555365; RRID:AB_395768
|
Biotin CD14 Monoclonal Antibody (61D3) |
eBioscience |
Cat#13-0149-82; RRID:AB_466373
|
Anti-human CD19 Antibody FITC (HIB19) |
BioLegend |
Cat#302206; RRID:AB_314236
|
Anti-human IgM Antibody APC/Cy7 (MHM-88) |
BioLegend |
Cat#314520; RRID:AB_10900422
|
Anti-Human IgG BV421 (G18-145) |
BD |
Cat#562581; RRID:AB_2737665
|
anti-human CD27 Antibody PE (M-T271) |
BioLegend |
Cat#356406; RRID:AB_2561825
|
APC-conjugated AffiniPure F(ab’)2 Fragment Goat Anti-Human IgG (H + L) |
Jackson ImmunoResearch |
Cat#109-136-088; RRID:AB_2337691
|
|
Bacterial and virus strains |
|
SARS-CoV-2 Japan/NGS-IA-1/2020 |
Sakurai et al., 2021 |
GISAID ID number: EPI_ISL_481251 |
SARS-CoV-2 Japan/TY7-503/2021 |
National Institute of Infectious Diseases, Japan |
GISAID ID number: EPI_ISL_877769 |
SARS-CoV-2 Japan/TY8-612-P1/2021 |
National Institute of Infectious Diseases, Japan |
GISAID ID number: EPI_ISL_1123289 |
SARS-CoV-2 Japan/QK002/2020 |
National Institute of Infectious Diseases, Japan |
GISAID ID number: EPI_ISL_768526 |
Stbl2 Competent Cells |
Invitrogen |
Cat#10268019 |
|
Biological samples |
|
Blood of SARS-CoV-2 infected patient A and B, See Table S1
|
This paper |
N/A |
Plasma of SARS-CoV-2 infected individuals, See Table S2
|
This paper |
N/A |
|
Chemicals, peptides, and recombinant proteins |
|
MojoSort Magnet |
BioLegend |
Cat#480019 |
7AAD |
BD |
Cat#559925 |
guanidine thiocyanate |
Invitrogen |
Cat#AM9422 |
dNTP-Mix (10mM) |
Invitrogen |
Cat#18427088 |
Recombinant RNase inhibitor |
Takara |
Cat#2313B |
Superscript III reverse transcriptase |
Invitrogen |
Cat#18080085 |
Sensor Chip CM5 |
cytiva |
Cat#BR100030 |
Human Antibody Capture Kit |
cytiva |
Cat#BR100839 |
Amine Coupling Kit |
cytiva |
Cat#BR100050 |
G418 |
Millipore |
Cat#345812-20ML |
Hygromycin B |
Nacalai Tesque |
Cat#09287-84 |
RBD |
This paper |
N/A |
NTD |
This paper |
N/A |
Protein A AlphaScreen Donor Beads |
PerkinElmer |
Cat#AS102D |
Anti-His AlphaLISA Acceptor beads |
PerkinElmer |
Cat#AL178C |
Carboxymethyl cellulose |
Sigma |
Cat#C9481-500G |
Methylene blue |
Nacalai Tesque |
Cat#22412-14 |
|
Critical commercial assays |
|
FectoPRO |
Polyplus-transfection |
Cat#116-010 |
FectoCHO Expression System |
Polyplus-transfection |
Cat#716-06LKIT |
Luciferase assay system |
Promega |
Cat#E4550 |
EnduRen |
Promega |
Cat#E6481 |
Gibson Assembly Master Mix |
New England Biolabs |
Cat#E2611L |
HiTrap rProtein A FF Column |
cytiva |
Cat#17507901 |
COSMOGEL His-Accept |
Nacalai Tesque |
Cat#09277-56 |
Superdex 75 Increase 10/300 GL |
cytiva |
Cat#29148721 |
|
Deposited data |
|
Antibody nucleotide sequence |
This paper |
GenBank accession number: MZ089617 to MZ089626
|
Structure of antibody (COVA2-04 or COVA2-39)-RBD complex |
Wu et al., 2020b |
PDB: 7JMO and 7JMP
|
Structure of 9-105-RBD complex |
This paper |
N/A |
|
Experimental models: cell lines |
|
293T |
ATCC |
CRL-3216 |
293A |
Invitrogen |
Cat#R70507
|
293FT/DSP1-7/ACE2/TMPRSS2 |
Yamamoto et al., 2020 |
N/A |
293FT/DSP8-11/SARS-CoV-2-S |
Yamamoto et al., 2020 |
N/A |
Calu3-DSP1-7 |
Yamamoto et al., 2020 |
N/A |
Calu-3 |
ATCC |
HTB-55 |
Caco-2 |
ATCC |
HTB-37 |
Vero |
ATCC |
CCL-81 |
ExpiCHO-S |
GIBCO |
Cat#A29127 |
|
Oligonucleotides |
|
Primer: 3′ Cγ CH1: GGAAGGTGTGCACGCCGCTGGTC |
Tiller et al., 2008 |
N/A |
Primer: HcnestU: GG(ACTAGT)TCTTGTCCACCTTGGTGTTG |
Coronella et al., 2000 |
N/A |
Primer: P1-Cκ (modified): CAGCAGGCACACAACAGAGGCAGTTCC |
He et al., 2014 |
N/A |
Primer: 3′ Cλ: CACCAGTGTGGCCTTGTTGGCTTG |
Tiller et al., 2008 |
N/A |
Primer: Lnest: GCTCTAGAACTAATGCGTGACCTGGCAGCTGT |
Coronella et al., 2000 |
N/A |
|
Recombinant DNA |
|
pIgGH |
Ramirez Valdez et al., 2015 |
N/A |
pKVA2 |
Ramirez Valdez et al., 2015 |
N/A |
pLSH |
Ramirez Valdez et al., 2015 |
N/A |
SARS-CoV-2 Spike ORF expression plasmid |
Sino Biological |
Cat#VG40589-UT |
pSARS-CoV-2-S-IRES-EGFP |
This paper |
N/A |
psPAX2-IN/HiBiT |
Ozono et al., 2020 |
N/A |
pWPI-Luc2 |
Ozono et al., 2020 |
N/A |
pC-SARS2-S-D614G |
Ozono et al., 2021 |
N/A |
pSARS-CoV-2-S-D614G-19del |
This paper |
N/A |
SARS-CoV S-expressing plasmid |
Sino Biological |
Cat#VG40150-G-N |
MERS-CoV S-expressing plasmid |
Sino Biological |
Cat#VG40069-G-N |
Plasmids to express pSARS-CoV-2 S variants |
This paper |
N/A |
Plasmids to express pSARS-CoV-2 S mutants |
This paper |
N/A |
|
Software and algorithms |
|
IMGT vquest |
Brochet et al., 2008 |
http://imgt.org/ |
PyIR |
Soto et al., 2020 |
https://github.com/crowelab/PyIR |
FlowJo |
TreeStar |
Version 10.7.1 https://www.flowjo.com
|
BIAevaluation |
GE healthcare |
Version 4.1 http://www.cytivalifesciences.com/country-selection?originalItemPath=%2f
|
Prism |
GraphPad Software |
Version 8.4.3 https://www.graphpad.com/scientific-software/prism/
|